Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interstitial lung disease in systemic sclerosis.

O Kaloudi1, I Miniati, S Alari

  • 1Department of Medicine & Surgery Div Medicine I & Rheumatology AOUC, University of Florence, Florence, Italy.

Internal and Emergency Medicine
|January 4, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort.

Arthritis research & therapy·2025
Same author

Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis.

Rheumatology (Oxford, England)·2024
Same author

Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort.

Scandinavian journal of rheumatology·2024
Same author

Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review.

European journal of internal medicine·2024
Same author

Rheumatic diseases in migrant patients resident in Tuscany: epidemiological data analysis and single-center experience.

Reumatismo·2024
Same author

The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review.

Respiratory research·2024
Same journal

Hypocholesterolemia as a predictor of mortality in infective endocarditis.

Internal and emergency medicine·2026
Same journal

Correction: Diagnostic accuracy and clinical impact of internist-performed point-of-care ultrasound in atrial fibrillation: a multicenter study.

Internal and emergency medicine·2026
Same journal

Managing emergency department overcrowding: analysis through a dynamic simulation model of the impact of organizational variables on emergency department processes.

Internal and emergency medicine·2026
Same journal

Gunshot-induced carotid artery injury: exploring other determined aetiologies of stroke.

Internal and emergency medicine·2026
Same journal

Machine learning phenotypes and heterogeneous albumin effects in cirrhotic AKI: a causal inference study.

Internal and emergency medicine·2026
Same journal

Factors affecting exercise performance at the 6-min walk test in long-COVID: a multicenter study from Italy.

Internal and emergency medicine·2026
See all related articles

Early diagnosis of lung involvement in systemic sclerosis (SSc) is crucial. High-resolution computed tomography (HRCT) and pulmonary function tests (PFTs) are key for detecting early interstitial lung disease.

Area of Science:

  • Pulmonology
  • Rheumatology
  • Radiology

Background:

  • Systemic sclerosis (SSc) frequently causes lung involvement, significantly impacting patient quality of life and survival.
  • Early detection of pulmonary complications in SSc is essential for timely intervention and improved outcomes.

Purpose of the Study:

  • To outline the diagnostic modalities for early detection and follow-up of interstitial lung disease in systemic sclerosis.
  • To emphasize the importance of a multi-modal diagnostic approach for pulmonary involvement in SSc.

Main Methods:

  • Pulmonary function tests (PFTs), including forced vital capacity (FVC) and diffusion capacity for carbon monoxide (DLCO).
  • High-resolution computed tomography (HRCT) for detailed lung imaging.
  • Lung scintigraphy with technetium-99m diethylenetriamine penta-acetic acid ((99m)Tc-DTPA) and bronchoalveolar lavage (BAL) via bronchoscopy.

Related Experiment Videos

Main Results:

  • PFTs assess lung function, with FVC and DLCO being critical measures.
  • HRCT is highly sensitive for detecting early lung involvement, even before symptoms manifest.
  • (99m)Tc-DTPA aids in differentiating vascular disease from fibrosing alveolitis, while BAL provides inflammatory status information.

Conclusions:

  • A combination of PFTs and HRCT is mandatory for diagnosing and monitoring SSc-related lung disease.
  • Bronchoscopy with BAL is valuable for detecting alveolitis, enabling prompt immunosuppressive treatment.
  • Early and accurate diagnosis through these methods is vital for managing SSc-induced pulmonary interstitium.